Is a complete NBP research report available?

No complete published report is available for NovaBridge Biosciences (NBP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

NovaBridge Biosciences (NBP)

NASDAQ: NBP · USD

$1.77

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NBP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	204.7M
Net income (ttm)	-88.3M
EPS (ttm)	-$0.92
Shares out	115.6M
Volume	199,379
Beta	1.45
Price target	$8.00	+352.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -88.3M
EPS (ttm): -$0.92
Market cap: 204.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NBP indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001778016
Company name	NovaBridge Biosciences
Country	United States
Country code	US
Cusip	44975P103
Employees	30
Employees Change	-2%
Employees Change Percent	-6.25
Enterprise value	$-3.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-01-17
Isin	US44975P1030
Last refreshed	2026-07-27
Market cap	$204.7M
Market cap category	Micro-Cap
Price	$1.77
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	NBP
Website	https://novabridge.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-43.16%
FCF yield	-10.07%
P/B ratio	0.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-88.3M
Net Income Growth Years	0%
Profit Per Employee	$-2.9M
ROA	-24.9
Roa5y	-13.75
ROCE	-40.35
ROE	-40.89
Roe5y	-31.98
ROIC	-330.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.12%
Cagr3y	-16.49%
Cagr5y	-52.51%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$260.5M
Cash	$210.8M
Current Assets	$217.5M
Current Liabilities	$26.9M
Debt	$3.1M
Debt Equity	$0.01
Equity	$230.9M
Liabilities	$29.6M
Long Term Assets	$43M
Long Term Liabilities	$2.7M
Net Cash	$207.8M
Net Cash By Market Cap	$102
Net Cash Growth	22.57%
Net Debt Equity	$-0.9
Tangible Book Value	$230.9M
Tangible Book Value Per Share	$2
WACC	12.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.09
Net Working Capital	$-19.3M
Quick ratio	7.91
Working Capital	$190.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.11%
200-day SMA	3.15
3Y total return	-41.78%
50-day SMA	1.76
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.58%
All Time High	85.4
All Time High Change	-97.93%
All Time High Date	2021-06-30
All Time Low	0.6
All Time Low Change	197.48%
All Time Low Date	2025-04-04
ATR	0.13
Beta	1.45
Beta1y	0.95
Beta2y	1.34
Ch YTD	-55.53
High	1.78
High52	6.79
High52 Date	2025-10-16
High52ch	-73.93%
Low	1.7
Low52	1.46
Low52 Date	2026-06-15
Low52ch	21.23%
Ma50ch	0.63%
Price vs 200-day SMA	-43.72%
RSI	47
RSI Monthly	40.32
RSI Weekly	38.1
Sharpe ratio	0.24x
Sortino ratio	0.46
Total Return	-17.96%
Tr YTD	-55.53
Tr1m	9.94%
Tr1w	-0.56%
Tr3m	-28.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.22
Operating Income	$-94.3M
Price target	$8
Price Target Change	$352

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,212,907%
Float Percent	55.52%
Shares Insiders	7.46%
Shares Institutions	20.24%
Shares Out	115,648,504
Shares Qo Q	10.88%
Shares Yo Y	17.96%
Short Ratio	5.18
Short Shares	5.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-26.6M
Average Volume	712,386.6x
Bv Per Share	2
CAPEX	$-7,000
Ch1m	9.94
Ch1w	-0.56
Ch1y	-16.11
Ch3m	-28.34
Ch3y	-41.78
Ch5y	-97.58
Ch6m	-54.5
Change	0%
Change From Open	0
Close	1.77
Days Gap	0
Depreciation Amortization	68,000
Dollar Volume	352,900.8
Earnings Date	2026-08-19
Earnings Time	bmo
EBIT	$-94.3M
EBITDA	$-94.2M
EPS	$-0.92
F Score	1
FCF	$-20.6M
FCF EV Yield	669.58x
FCF Per Share	$-0.18
Financing CF	57,725,000
Fiscal Year End	December
Founded	2,014
Investing CF	104,965,000
Iprfo	-88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-07
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-07
Ma150	2.7
Ma150ch	-34.37%
Ma20	1.87
Ma20ch	-5.35%
Net CF	142,369,000
Next Earnings Date	2026-08-19
Open	1.77
Optionable	Yes
Position In Range	87.5
Post Close	1.77
Postmarket Change Percent	3.54
Postmarket Price	$1.83
Ppne	2,949,000
Price Date	2026-07-24
Ptbv Ratio	0.89
Relative Volume	0.28x
Share Based Comp	5,974,000
Tr6m	-54.5%
Us State	Maryland
Volume	199,379

NovaBridge Biosciences (NBP)

Coverage state: Market snapshot only — no published research

Generate the first NBP analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NBP

Frequently asked questions